The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).
Carotid Artery Stenting
Study Type
OBSERVATIONAL
Enrollment
21,008
Christiana Care Health Services
Newark, Delaware, United States
Iowa Clinic, Heart & Vascular Care
West Des Moines, Iowa, United States
Bryan LGH Heart Institute
Lincoln, Nebraska, United States
Harrisburg Hospital
Harrisburg, Pennsylvania, United States
Any death, stroke or any MI
Time frame: up to 30-days post-procedure
Assess the consistency of MAE rates of stenting with distal protection in the treatment of obstructive carotid artery disease among high, medium and low volume centers with physicians who have validated CASES training levels of 1, 2, 2P or 3
Time frame: 30 days
Assess the real-world cost-effectiveness of carotid artery stenting in subjects enrolled
Time frame: Every follow-up where a PRO instrument QoL was assessed
Estimate MAE (death and ipsilateral stroke) rate in a subset of the planned total enrollment
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Heart Center, PC
Kingsport, Tennessee, United States